Investigation of IL23 (p19, p40) and IL23R highlights nuclear IL23p19 expression as a marker of indolent tumor features and favorable outcome in colorectal cancer patients

Zlobec, Inti; Kölzer, Viktor; Dawson, Heather; Langer, Rupert; Karamitopoulou, Evanthia; Lugli, Alessandro (2013). Investigation of IL23 (p19, p40) and IL23R highlights nuclear IL23p19 expression as a marker of indolent tumor features and favorable outcome in colorectal cancer patients. Virchows Archiv, 463(2), pp. 139-140. Springer 10.1007/s00428-013-1444-y

[img]
Preview
Text
Zlobec_Investigation_of_IL23.pdf - Published Version
Available under License Publisher holds Copyright.

Download (166kB) | Preview

Objective: IL23 is involved in chronic inflammation but its role in cancer
progression is not fully elucidated. Here we characterize IL23 subunits
p40, p19 and IL23 receptor (IL23R) in the normal-adenoma-carcinomametastasis
cascade of colorectal cancers and their relationship to clinicopathological
and outcome data.
Method: Immunohistochemistry for IL23R, IL12p40, IL23 and IL23p19
(monoclonal) was performed on a multi-punch tissue microarray (n=213
patients). Expression differences between normal-adenomas-cancerslymph
nodes were evaluated. Correlation with clinicopathological and
outcome data was undertaken. Results were validated on an independent
cohort (n=341 patients).
Results: An increased expression from normal-adenoma-cancer was observed
(p<0.0001; all) followed by a marked reduction in lymph nodes (p<0.0001;
all). Cytoplasmic and/or membranous staining of all markers was unrelated to
outcome. Nuclear IL23p19 staining occurred in 23.1%and was associated with
smaller tumor diameter (p=0.0333), early pT (p=0.0213), early TNM
(p=0.0186), absence of vascular (p=0.0124) and lymphatic invasion
(p=0.01493) and favorable survival (univariate (p=0.014) and multivariable
(p=0.0321) analysis). All IL23p19 positive patients were free of distant metastasis
(p=0.0146). Survival and metastasis results could be validated in Cohort 2.
Conclusion: The presence of nuclear IL23p19 is related to indolent tumor
features and favorable outcome supporting a more ‘protective’ role of this
protein in colorectal cancer progression

Item Type:

Conference or Workshop Item (Abstract)

Division/Institute:

04 Faculty of Medicine > Service Sector > Institute of Pathology > Clinical Pathology
04 Faculty of Medicine > Service Sector > Institute of Pathology

UniBE Contributor:

Zlobec, Inti, Kölzer, Viktor, Dawson, Heather, Langer, Rupert, Karamitopoulou Diamantis, Evanthia, Lugli, Alessandro

Subjects:

500 Science > 570 Life sciences; biology
600 Technology > 610 Medicine & health

ISSN:

0945-6317

Publisher:

Springer

Language:

English

Submitter:

Andrea Arnold

Date Deposited:

31 Mar 2014 17:39

Last Modified:

02 Mar 2023 23:24

Publisher DOI:

10.1007/s00428-013-1444-y

PubMed ID:

23925389

BORIS DOI:

10.48350/47049

URI:

https://boris.unibe.ch/id/eprint/47049

Actions (login required)

Edit item Edit item
Provide Feedback